Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10485372 | Value in Health | 2005 | 14 Pages |
Abstract
This review shows that cost-effectiveness results for pharmaceuticals vary from country to country in Western Europe and that these variations are not systematic. In addition, constraints imposed by analysts may reduce apparent variability in the estimates. The lessons for inferring generalizability are not straightforward, although the implications of variation for decision making depend critically on the cost-effectiveness thresholds applying in Western Europe.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Marco MSc, Michael DPhil, Richard PhD, Jeremy MSc, Bruno MD, Adrian MA, MPhil,